<http://schema.org/articleBody>
" Women with ovarian cancer who have a faulty BRCA gene are much more likely to survive the disease than those without these gene faults, a study has found. About ten per cent of women with epithelial ovarian cancer - the most common form of the disease - carry BRCA1 or BRCA2 faults or &amp;#039;mutations&amp;#039;. Scientists at the University of Cambridge have now discovered that, despite having up to a 40 per cent chance of developing ovarian cancer by the age of 70, women with faulty BRCA genes are more likely to survive the disease. Their study, which is published in the Journal of the American Medical Association, combined the results of 26 international trials. Analysis revealed that 44 per cent of women with BRCA1 faults and 52 per cent with BRCA2 faults were still alive five years after diagnosis, compared with just 36 per cent of women without BRCA faults. Lead author Dr Paul Pharoah, from the University of Cambridge, said: &amp;#039;Our results could change the way ovarian cancer is treated. &amp;#039;Women with BRCA faults respond better than we thought to current treatments but it&amp;#039;s important that researchers now look at what treatment approaches work best for women without those genetic faults.&amp;#039; "^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.netdoctor.co.uk/healthy-living/news/a21991/women-with-faulty-brca-genes-more-likely-to-survive-ovarian-cancer/>